Mathieu Chevrier

Stock Analyst at Citigroup

(2.36)
# 2,437
Out of 4,840 analysts
2
Total ratings
100%
Success rate
9.13%
Average return
Main Sectors:

Stocks Rated by Mathieu Chevrier

ResMed
Mar 5, 2025
Upgrades: Buy
Price Target: n/a
Current: $242.84
Upside: -